]>
IRCT20190305042937N1 IRCT 2019-08-10 Ghoum University of Medical Sciences effect of folic acid and vitamin D in stroke Clinical trial Comparison of the Effect of Folic Acid and Vitamin D Supplementation in the Prevention of Cerebrovascular Attacks in Patients Referred to Shahid Beheshti Hospital in 3 Months 2019-07-23 anticipated 120 Complete https://irct.ir/trial/40282 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Factorial, Purpose: Treatment, Randomization description: The random allocation method is based on blocking. Four blocks are used. The list of 24 blocks is written and randomly a number is selected and the sampling is continued based on it ABCD, ABDC, ACBD, ACDB, ADBC, ADCB, BACD, BADC, BCAD, BCDA, BDAC, BDCA, CABD, CADB, CBAD, CBDA, CDAB, CDBA, DABC, DACB, DBCA, DBAC, DCAB, DCBA, Blinding description: Medications and placebo are packed in one form. The packages are written in abbreviated form A, B, C and D and delivered to the secretary. It should be noted that the secretary does not know the content of the packages. According to the patient's entry into the plan, depending on the outcome of the patient's blockage, the packet will be delivered and detailed descriptions of how the medications will be given by the clerk. 3 Brain stroke. Intervention 1: Intervention group: Group B: A stroke group that is treated with oral administration of oral folic acid for a period of three months at a dose of 5 mg once a day. Along with vitamin D placebo. Intervention 2: Intervention group: Group C: A group of patients with a stroke who is given a prescription for vitamin D in addition to routine treatment for a period of three months at a dose of 1000 IU once a day. With Folic Acid Placebo. Intervention 3: Intervention group: Group D: A group of patients suffering from stroke, administered in addition to routine treatment, administered folic acid for a period of three months at a dose of 5 mg once a day and a prescriptive vitamin D administered at a dose of 1000 IU once a day. Intervention 4: Control group: Control group A: Stroke patients undergoing routine treatment. Along with the placenta two other drugs. Yes - There is a plan to make this available What will be shared: Part of the information is shared after deleting the name of the identifier When: Start access after article release To whom: Only for researchers Conditions: Just use to have background for future studies Where to obtain: Neuroscience Research Center of Shahid Beheshti Hospital How to obtain: Email to the Head of Neurology Department of Qom University of Medical Sciences Comments:
public Ehsan Sharifipur
Beheshti hospital - Qom
Qom Iran (Islamic Republic of) 3713649373 +98 25 3770 6470 ehsansharifipoor@yahoo.com Ghoum University of Medical Sciences scientific Ehsan sharifipur
Shahid beheshti, Qom
Qom Iran (Islamic Republic of) 3713649373 +98 25 3770 6470 ehasnsharifipoor@yahoo.com Ghoum University of Medical Sciences Iran (Islamic Republic of) No previous use of supplements No pregnancy Ability to swallow medicine Not having a history of allergy Individual consent First episode of stroke 30 years no limit Both Pregnancy Not ability to swallow medicine G90-G99 Other disorders of the nervous system Treatment - Drugs Treatment - Drugs Treatment - Drugs Placebo Intervention group: Group B: A stroke group that is treated with oral administration of oral folic acid for a period of three months at a dose of 5 mg once a day. Along with vitamin D placebo Intervention group: Group C: A group of patients with a stroke who is given a prescription for vitamin D in addition to routine treatment for a period of three months at a dose of 1000 IU once a day. With Folic Acid Placebo Intervention group: Group D: A group of patients suffering from stroke, administered in addition to routine treatment, administered folic acid for a period of three months at a dose of 5 mg once a day and a prescriptive vitamin D administered at a dose of 1000 IU once a day. Control group: Control group A: Stroke patients undergoing routine treatment. Along with the placenta two other drugs Occurrence of recurrent stroke. Timepoint: once a month. Method of measurement: NIHSS questionnaire. Ghoum University of Medical Sciences Approved 2018-12-04 Ethics Committee of Qom University of Medical Sciences Research Deputy, Safashahr Ave, Mohammadamin Ave Qom Ghoum Iran (Islamic Republic of)